Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.
about
Immune stimulation following dermal exposure to unsintered indium tin oxideA rare case of acute kidney injury associated with autoimmune hemolytic anemia and thrombocytopenia after long-term usage of oxaliplatin.Adverse reactions to targeted and non-targeted chemotherapeutic drugs with emphasis on hypersensitivity responses and the invasive metastatic switch.Comparison between hypersensitivity reactions to cycles of modified FOLFOX6 and XELOX therapies in patients with colorectal cancerFatal carboplatin-induced immune hemolytic anemia in a child with a brain tumor.Effect of the Combination of Trabectedin and Pegylated Liposomal Doxorubicin in a BRCA2 Mutation Carrier with Recurrent Platinum-Sensitive Ovarian Cancer.Platinum agent-induced hypersensitivity reactions: data mining of the public version of the FDA adverse event reporting system, AERS.Management of hypersensitivity to platinum- and taxane-based chemotherapy: cepo review and clinical recommendationsRisk factors for oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancerCarboplatin-induced severe hypersensitivity reaction: role of IgE-dependent basophil activation and FcεRI.Carboplatin-induced hypersensitivity reaction.Oxaliplatin-induced lung injury with allergic reaction.Deleterious BRCA1/2 mutation is an independent risk factor for carboplatin hypersensitivity reactionsHypersensitivity to oxaliplatin: clinical features and risk factors.Serum lactate dehydrogenase levels as a predictive marker of oxaliplatin-induced hypersensitivity reactions in Japanese patients with advanced colorectal cancer.Rechallenge to Carboplatin in Children with Low Grade Glioma and Carboplatin Hypersensitivity Reactions.Hypersensitivity to antineoplastic agents: mechanisms and treatment with rapid desensitization.Drug desensitization in the management of hypersensitivity reactions to monoclonal antibodies and chemotherapy.4-step 4-h carboplatin desensitization protocol for patients with gynecological malignancies showing platinum hypersensitivity: a retrospective study.Treatment outcomes of rapid desensitisation protocols for chemotherapeutic agents and monoclonal antibodies following hypersensitivity reactions.Oxaliplatin for the treatment of ovarian cancer.Adjunct Histamine Blockers as Premedications to Prevent Carboplatin Hypersensitivity Reactions.Hypersensitivity to Carboplatin in Children with Malignancy.Systemic capillary leak syndrome in a patient receiving adjuvant oxaliplatin for locally advanced colon cancer.Prevention of carboplatin-induced hypersensitivity reactions in women with ovarian cancer.The safety of antiangiogenic agents and PARP inhibitors in platinum-sensitive recurrent ovarian cancer.Hypotension due to Chemotherapy in a Patient with Small Cell Lung Cancer and Lambert-Eaton Myasthenic Syndrome Undergoing Hemodialysis: A First Case Report.Drug Hypersensitivity and Anaphylaxis in Cancer and Chronic Inflammatory Diseases: The Role of Desensitizations.Chemotherapy reaction induced by ixabepilone, a microtubule stabilizing agent, mimicking extramammary Paget's disease in a patient with breast carcinoma.Designing new iridium(iii) arene complexes of naphthoquinone derivatives as anticancer agents: a structure-activity relationship study.Cisplatin-induced sudden cardiac death with hemodynamic collapse: a severe adverse drug reaction: Case report.Incidence of and risk factors associated with nedaplatin-related hypersensitivity reactions.Retrospective study of hypersensitivity reactions to chemotherapeutic agents in a thoracic oncology service.Platinum or nonplatinum in recurrent ovarian cancer: that is the question.Iridium(I) Compounds as Prospective Anticancer Agents: Solution Chemistry, Antiproliferative Profiles and Protein Interactions for a Series of Iridium(I) N-Heterocyclic Carbene Complexes.Pediatric Optic Pathway/Hypothalamic Glioma.Recurrent cisplatin hypersensitivity reaction after first exposure: A case report.Carboplatin Hypersensitivity Reactions in Pediatric Low Grade Glioma Are Protocol Specific and Desensitization Shows Poor Efficacy.Impact of drug formulation and free platinum/cisplatin ratio on hypersensitivity reactions to cisplatin: formulation matters
P2860
Q23916383-1676761F-17BC-49D9-8EE3-9A1125E35352Q33400418-12F6A893-4DD6-44E9-A2EF-548C24E77EF5Q33410375-E272A4D5-C897-462F-91A4-D7B406904C8EQ33600062-439AD554-5ACF-480B-804D-586CAB56967DQ33650643-047F2603-27D0-4CB8-8B87-8FEDCC9253E1Q33801643-A7BBF3ED-89B7-4E9C-A900-A0CF65B9D805Q33911016-D91FEF74-E18A-4D01-829B-F61F202F681CQ33982751-9A868C7E-BA11-474F-9305-6B9CEDA7B0A0Q34648284-7776FA0C-F20A-4C57-80DB-61A4C63C3316Q35713385-4D7CEB07-FAD9-47A0-AC5F-6D3C8BBF891FQ35998211-526EF80D-5FC3-48AB-A0F8-2723CC25CCE4Q36654724-FB5199A1-1157-4540-9757-FA2F3017732AQ37111145-63ED29BC-640F-4E6D-85AB-EDBF76DCD7E5Q37497459-7AC272AC-8137-41CA-AE12-A3CA686CDB3CQ37730274-F90C7669-96B5-400A-A607-66151D361836Q37740616-5C9F67E9-8541-4C01-9F70-1358144BB5CAQ38009188-C1FC0C7A-A628-4BED-87F7-06753D78AD58Q38132699-2D3AEEB6-7E6E-4316-9328-49FB86702838Q38230264-0480BF4C-6B58-4FAF-89FF-7A1BAA3F5788Q38393480-672FE2A2-398B-4643-BD4C-8D63E1959EC8Q38540596-B1AC17B8-D7FE-4CDB-AA92-2EBBE5E21B97Q38779659-67137312-E530-4636-815B-CC6F6957274AQ38817913-8A809E3A-30C8-44E7-A2A1-26704FA86A65Q38996049-658DCA2A-30A0-4A93-BCF3-E8DB0C1D7399Q39179349-DBCAECF1-BEE5-4A88-9A8B-E5162711F373Q39282981-A4ACA934-B3A8-4CC9-AE72-A26E1E1289A3Q42581091-C6EAEA99-E647-47FC-8BAA-DEE0AFAAF122Q44842257-6C15B0D7-99DE-4167-A34E-FDFEF8C83FCAQ46282808-A29A9CF4-BA4E-4E0F-BE42-193127A8B34CQ46425575-EB00FD24-C32E-4EB3-BF7C-B00108FB33CBQ47124163-9AA456C8-BB1A-4B28-9A19-5CD72066821EQ47576894-8101E325-CB0E-45D9-91E5-202BBA3250DFQ47865412-96B8046F-82B1-43D4-A04D-0A4DADDC61E5Q47903289-8FB4D671-F85A-43B6-AC3D-6C8164502F5EQ48148699-D6694430-3DF1-433F-99B2-14D92B39BFD9Q49203220-ACD0F02F-2247-494C-9C9E-7CF7203F392FQ50097707-6E373C8B-82A8-49B5-BE4E-C4CC548F6B45Q55459950-D74D86AC-0D19-46BC-9504-62187CA9ACA7Q56763984-6574B6A7-4FD8-4061-81D1-B13115615956
P2860
Hypersensitivity reactions associated with platinum antineoplastic agents: a systematic review.
description
2010 nî lūn-bûn
@nan
2010 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2010 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
name
Hypersensitivity reactions ass ...... c agents: a systematic review.
@ast
Hypersensitivity reactions ass ...... c agents: a systematic review.
@en
Hypersensitivity reactions ass ...... c agents: a systematic review.
@nl
type
label
Hypersensitivity reactions ass ...... c agents: a systematic review.
@ast
Hypersensitivity reactions ass ...... c agents: a systematic review.
@en
Hypersensitivity reactions ass ...... c agents: a systematic review.
@nl
prefLabel
Hypersensitivity reactions ass ...... c agents: a systematic review.
@ast
Hypersensitivity reactions ass ...... c agents: a systematic review.
@en
Hypersensitivity reactions ass ...... c agents: a systematic review.
@nl
P2093
P2860
P356
P1433
P1476
Hypersensitivity reactions ass ...... c agents: a systematic review.
@en
P2093
Ekaterini Syrigou
Ioannis Kaklamanos
Leonidas Manolopoulos
Muhammad Wasif Saif
Nektaria Makrilia
P2860
P304
P356
10.1155/2010/207084
P577
2010-09-20T00:00:00Z